Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States

Open Forum Infectious Diseases

Volumn 2, Issue 3, 2015, Pages

  Diaz, Maureen H ^a   Benitez, Alvaro J ^a   Cross, Kristen E ^a   Hicks, Lauri A ^a   Kutty, Preeta ^a   Bramley, Anna M ^a   Chappell, James D ^c   Hymas, Weston ^g   Patel, Anami ^e,f   Qi, Chao ^b   Williams, Derek J ^c,d   Arnold, Sandra R ^e,f   Ampofo, Krow ^g   Self, Wesley H ^c   Grijalva, Carlos G ^c   Anderson, Evan J ⁱ   McCullers, Jonathan A ^e,f,h   Pavia, Andrew T ^g   Wunderink, Richard G ^b   Edwards, Kathryn M ^c,d   Jain, Seema ^a   Winchell, Jonas M ^a   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e LE BONHEUR CHILDREN S HOSPITAL   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^h ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

community acquired pneumonia; macrolide resistance; molecular epidemiology; Mycoplasma pneumonia

Indexed keywords

EID: 84961243104     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/OFID/OFV106     Document Type: Article

References (40)

1. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008; 32:956-73.
2. Winchell JM. Mycoplasma pneumoniae - A National Public Health Perspective. Curr Pediatr Rev 2013; 9:324-33.
3. Schwartz SB, Mitchell SL, Thurman KA, et al. Identification of P1 variants of Mycoplasma pneumoniae by use of high-resolution melt analysis. J Clin Microbiol 2009; 47:4117-20.
4. Benitez AJ, Diaz MH, Wolff BJ, et al. Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study. J Clin Microbiol 2012; 50:3620-6.
5. Degrange S, Cazanave C, Charron A, et al. Development of multiplelocus variable-number tandem-repeat analysis for the molecular typing of Mycoplasma pneumoniae. J Clin Microbiol 2009; 47:914-23.
6. Li X, Atkinson TP, Hagood J, et al. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J 2009; 28:693-6.
7. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and highresolution melt analysis. Antimicrob Agents Chemother 2008; 52: 3542-9.
8. Cao B, Zhao CJ, Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis 2010; 51: 189-94.
9. Matsubara K, Morozumi M, Okada T, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother 2009; 15:380-3.
10. Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother 2004; 48:4624-30.
11. Morozumi M, Iwata S, Hasegawa K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother 2008; 52:348-50.
12. Suzuki S, Yamazaki T, Narita M, et al. Clinical evaluation of macrolideresistant Mycoplasma pneumoniae. Antimicrob Agents Chemother 2006; 50:709-12.
13. Cardinale F, Chironna M, Chinellato I, et al. Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children. J Clin Microbiol 2013; 51:723-4.
14. Liu Y, Ye X, Zhang H, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrob Agents Chemother 2009; 53:2160-2.
15. Xin D, Mi Z, Han X, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother 2009; 53:2158-9.
16. Yamada M, Buller R, Bledsoe S, Storch GA. Rising rates of macrolideresistant Mycoplasma pneumoniae in the central United States. Pediatr Infect Dis J 2012; 31:409-11.
17. Diaz M, Benitez AJ, Winchell JM. Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance, 2006-2013. J Clin Microbiol 2015; 53:124-30.
18. Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 2015; 372:835-45.
19. Winchell JM, Thurman KA, Mitchell SL, et al. Evaluation of three realtime PCR assays for the detection of Mycoplasma pneumoniae in an outbreak investigation. J Clin Microbiol 2008; 46:3116-8.
20. Thurman KA, Warner AK, Cowart KC, et al. Detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. in clinical specimens using a single-tube multiplex real-time PCR assay. Diagn Microbiol Infect Dis 2011; 70:1-9.
21. Tully JG, Rose DL, Whitcomb RF, Wenzel RP. Enhanced isolation of Mycoplasma pneumoniae from throat washings with a newly modified culture medium. J Infect Dis 1979; 139:478-82.
22. Schwartz SB, Thurman KA, Mitchell SL, et al. Genotyping of Mycoplasma pneumoniae isolates using real-time PCR and high-resolution melt analysis. Clin Microbiol Infect 2009; 15:756-62.
23. Sun H, Xue G, Yan C, et al. Multiple-locus variable-number tandemrepeat analysis of Mycoplasma pneumoniae clinical specimens and proposal for amendment ofMLVA nomenclature. PLoS One 2013; 8:e64607.
24. Bebear C, Pereyre S, Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol 2011; 6: 423-31.
25. Steffens I, Hagmaier K, Wilson W, Wilson KE. Mycoplasma pneumoniae and Legionella pneumophila [Special edition]. 17th ed. Sweden, Stockholm: Eurosurveillance, 2012.
26. Babady NE. The FilmArray(R) respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens. Expert Rev Mol Diagn 2013; 13:779-88.
27. Ratliff AE, Duffy LB, Waites KB. Comparison of the illumigene Mycoplasma DNA amplification assay and culture for detection of Mycoplasma pneumoniae. J Clin Microbiol 2014; 52:1060-3.
28. Lind K, Benzon MW, Jensen S, Clyde WA Jr. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50- year period 1946 to1995. Eur J Epidemiol 1997; 13:581-6.
29. Pereyre S, Charron A, Renaudin H, et al. First report of macrolideresistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol 2007; 45: 3534-9.
30. Spuesens EB, Hoogenboezem T, Sluijter M, et al. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing. J Microbiol Methods 2010; 82:214-22.
31. Dumke R, Jacobs E. Culture-independent multi-locus variable-number tandem-repeat analysis (MLVA) of Mycoplasma pneumoniae. J Microbiol Methods 2011; 86:393-6.
32. Pereyre S, Charron A, Hidalgo-Grass C, et al. The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel. PLoS One 2012; 7:e38585.
33. Zhao F, Liu G, Cao B, et al. Multiple-locus variable-number tandemrepeat analysis of 201 Mycoplasma pneumoniae isolates from Beijing, China, from 2008 to 2011. J Clin Microbiol 2013; 51:636-9.
34. Waller J, Diaz M, Petrone B, et al. Detection and characterization of Mycoplasma pneumoniae during an outbreak of Respiratory illness at a university. J Clin Microbiol 2014; 52:849-53.
35. Critchley IA, Jones ME, Heinze PD, et al. In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe. Clin Microbiol Infect 2002; 8:214-21.
36. Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolideresistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect 2010; 16:613-6.
37. Zhao F, Liu G, Wu J, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother 2013; 57:1521-3.
38. McCaig LF, Hicks LA, Roberts RM, Fairlie TA. Office-related antibiotic prescribing for persons aged
39. Chironna M, Sallustio A, Esposito S, et al. Emergence of macrolideresistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother 2011; 66:734-7.
40. Dumke R, Stolz S, Jacobs E, Juretzek T. Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia. Int J Infect Dis 2014; 29C:197-9.